SUBSCRIBE
SUBSCRIBE

Genentech, Inc.

NEWS
Deals
Genentech, Inc.'s Levinson May Have No Change-of-Control Agreement in Roche Deal
March 13, 2009
 · 
1 min read
Biogen Idec, Inc. (California) And Genentech, Inc.'s Rituxan Can Cut Kidney Inflammation In Lupus, Imperial College London Study
March 5, 2009
 · 
1 min read
Biotech Bay
Another Possible Alzheimer’s Culprit Found, Genentech, Inc. And Salk Institute for Biological Studies Study
February 19, 2009
 · 
1 min read
Drug Development
Genentech, Inc. And Biogen Idec, Inc. (California)'s Rituximab Maintenance Therapy Improves Survival In Patients With Relapsed Follicular Lymphoma, Rabin Medical Center (Beilinson Hospital) Study
February 11, 2009
 · 
1 min read
REACH Call and Genentech, Inc. Provide Stroke Education to Telestroke Customers
January 26, 2009
 · 
1 min read
Biotech Bay
University of California, San Diego (UCSD) and Genentech, Inc. Scientists Develop Potentially Disruptive Antibody Sequencing Technology
December 19, 2008
 · 
1 min read
Biotech Bay
Genentech, Inc. Scientists Grow Mouse Prostate From A Single Cell
October 23, 2008
 · 
1 min read
Genentech, Inc. (JOBS), Roche (JOBS) Cancer Drug Avastin May Work as Imaging Tool Too
October 22, 2008
 · 
1 min read
Policy
MedWatch: FDA Approves Updated Labeling for Psoriasis Drug Raptiva
October 21, 2008
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Press Releases
Genentech to Present Extensive Data Showcasing Its Industry-Leading Ophthalmology Portfolio at ARVO 2026
April 30, 2026
 · 
15 min read
Press Releases
Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026
April 30, 2026
 · 
11 min read
Press Releases
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong sales growth of +6% at constant exchange rates in the first quarter of 2026; -5% in CHF due to the significant appreciation of the Swiss franc
April 23, 2026
 · 
20 min read
Press Releases
Genentech’s Fenebrutinib Significantly Reduced Relapses Versus Standard of Care to Approximately One Every 17 Years in RMS
April 22, 2026
 · 
15 min read
Press Releases
Genentech’s Enspryng (Satralizumab) Reduces Risk of Relapses by 68% Demonstrating Potential to Become First Treatment for MOGAD
April 22, 2026
 · 
12 min read
Press Releases
Roche’s ENSPRYNG (satralizumab) reduces risk of relapses by 68% demonstrating potential to become first treatment for MOGAD
April 21, 2026
 · 
9 min read
Press Releases
CORRECTING and REPLACING FDA Accepts Application for Genentech’s Gazyva for the Treatment of the Most Common Form of Lupus
April 21, 2026
 · 
15 min read
Press Releases
FDA Accepts Application for Genentech’s Gazyva for the Treatment of the Most Common Form of Lupus
April 21, 2026
 · 
14 min read
Press Releases
Roche expands mass spectrometry menu to include steroid assays receiving CLIA ‘moderate complexity’ designation
March 18, 2026
 · 
4 min read
Press Releases
Genentech Provides Update on Phase III persevERA Study in ER-positive Advanced Breast Cancer
March 9, 2026
 · 
7 min read
Load More